Current Medical Use of Rx Stimulants for ADHD Up in Teens From 2005 to 2023

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 5, 2025.

via HealthDay

TUESDAY, Aug. 5, 2025 -- Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and 2023, while nonmedical use decreased, according to a research letter published online July 29 in the Journal of the American Medical Association.

Sean Esteban McCabe, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined trends in medical and nonmedical prescription stimulant use patterns for ADHD among U.S. adolescents. The analysis included data from 259,623 students (eighth, 10th, and 12th grades) participating in the Monitoring the Future study (2005 to 2023).

The researchers found that lifetime medical use of prescription stimulants for ADHD peaked in 2022 at 9.30 percent. There was a linear, nonsignificant trend. The lowest point for lifetime nonmedical use was 4.69 percent in 2023, with a significant decrease over time (adjusted odds ratio [aOR] linear trend, 0.971). For current medical use of prescription stimulants, the peak was in 2022 at 4.46 percent, with modest increases over time (aOR linear trend, 1.016). Among participants with current medical use, 14.5 percent had used prescription stimulants for less than one year, 18.6 percent for one to two years, and 66.9 percent for three years or longer. Over time, current medical and nonmedical co-use decreased (aOR linear trend, 0.980). Participants in 10th and 12th grade had a greater prevalence of nonmedical use of prescription stimulants but also experienced greater declines in nonmedical use over time.

"Despite concerns about increased stimulant prescribing, findings indicate no associated increase in nonmedical prescription stimulant use at this time, although longitudinal research and continued monitoring is necessary," the authors write.

One author disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords